• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

GlucoTrack, Inc. - Common Stock (NQ:GCTK)

1.210 -0.200 (-14.18%)
Delayed Quote Updated: 4:00 PM EDT, Oct 2, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 301,423
Open 1.340
Bid (Size) 1.170 (100)
Ask (Size) 1.240 (300)
Prev. Close 1.410
Today's Range 1.150 - 1.340
52wk Range 1.150 - 136.29
Shares Outstanding 910,688
Dividend Yield N/A
Chart for  (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
Lōkahi Therapeutics™ Expands University of Georgia Collaboration Through First International ai² Pipeline™ Project with Universität Paderborn
October 01, 2026
From Lōkahi Therapeutics
Via Business Wire
News headline image
Lōkahi Therapeutics™ Announces Qare™, the First Real-Time Comparative Health Platform for GLP-1 Medications, with Public Availability Beginning October 14
September 30, 2026
From Lōkahi Therapeutics
Via Business Wire

Performance

52-Week Range 99.1% below 52-week high
1.210
1.1552W Low 136.2952W High
1 Week 37.9% below 1-week high
1.151W Low 1.951W High

GlucoTrack, Inc. - Common Stock (GCTK) traded between $1.15 and $136.29 over the past 52 weeks and last traded at $1.21, 99.1% below its 52-week high. Over the past week it ranged between $1.15 and $1.95.

Past 12 Months
-32.8%
-65.7%
-74.6%
-90.3%
-97.9%
-98.8%
1W -$0.59
1M -$2.32
3M -$3.56
6M -$11.24
YTD -$56.99
1Y -$98.39

GCTK was -98.8% over the past year, -90.3% over six months, -97.9% year to date, -32.8% in the last week.

12 Months vs Market
GCTK
-98.8%
DIA
+9.9%
SPY
+15.0%
QQQ
+23.7%
IWM
+15.4%

Over the past 12 months GCTK returned -98.8% versus DIA (Dow) +9.9%, SPY (S&P 500) +15.0%, QQQ (Nasdaq 100) +23.7% and IWM (Russell 2000) +15.4%.

Volume & Liquidity 0.15× 3-mo avg
Today 301,423 3-mo avg 2.0M
1W
577.5K
1M
3.9M
3M
2.0M
6M
1.2M
YTD
808.7K
1Y
607.6K

GCTK most recently traded 301,423 shares against a 3-month average daily volume of 2.0M.

More News

Read More
Top movers in Friday's session ↗
September 25, 2026
Via Chartmill
Top movers analysis in the middle of the day on 2026-09-25: top gainers and losers in today's session. ↗
September 25, 2026
Via Chartmill
News headline image
Lōkahi Therapeutics™ Expands ai2 Pipeline™ Program Through Collaboration with Pepperdine E2B™
September 25, 2026
From Lōkahi Therapeutics
Via Business Wire
News headline image
Emerging Growth DRK GLND APUS GCTK Stocks in the News
September 24, 2026
Via AB Newswire
Topics Artificial Intelligence
News headline image
DarkHorse (NASDAQ: DRK) Strategic Partners Power Up AI Data Center Expansion Across TVA Region
September 24, 2026
Via AB Newswire
Topics Artificial Intelligence
Unusual volume stocks in Thursday's session ↗
September 24, 2026
Via Chartmill
Which stocks are moving on Thursday? ↗
September 24, 2026
Via Chartmill
The market is filled with gapping stocks in Thursday's session. ↗
September 24, 2026
Via Chartmill
News headline image
Glucotrack, Inc. Announces Pricing of $3 Million Public Offering
September 24, 2026
From Glucotrack, Inc.
Via Business Wire
Wondering what's happening in today's pre-market session? ↗
September 24, 2026
Via Chartmill
Stay updated with the stocks that are on the move in today's after-hours session. ↗
September 23, 2026
Via Chartmill
News headline image
Lōkahi Therapeutics™ Advances its Proprietary ai² PIPELINE (formerly ai² Futures Lab) Process from Internal Asset Engine to Revenue-Generating Platform
September 23, 2026
From Lōkahi Therapeutics
Via Business Wire
News headline image
Lōkahi Therapeutics™ and Glucotrack CEO Erik Emerson Provides Strategic Update on LT-100, ai² Platform Growth and Clinical Development Priorities
September 23, 2026
From Lōkahi Therapeutics
Via Business Wire
News headline image
Lōkahi Therapeutics™ Continues ai² Pipeline™ Division Collaboration with The University of Alabama to Advance Asset Evaluation and Biopharma Talent
September 18, 2026
From Lōkahi Therapeutics
Via Business Wire
Top movers in Friday's session ↗
September 11, 2026
Via Chartmill
Let's have a look at the top gainers and losers in the middle of the day of today's session. ↗
September 11, 2026
Via Chartmill
Traders are paying attention to the gapping stocks in Friday's session. ↗
September 11, 2026
Via Chartmill
News headline image
Glucotrack Announces $11.5 Million Financing
September 11, 2026
From Glucotrack, Inc.
Via Business Wire
News headline image
Lōkahi Therapeutics™ Expands ai² Into Three Opportunity-Creating Business Divisions
September 08, 2026
From Lōkahi Therapeutics Inc.
Via Business Wire
News headline image
Lōkahi Therapeutics™ Expands ai² Futures Lab™ Asset Origination Network Through Collaboration with San Diego State University Fowler College of Business
September 02, 2026
From Lōkahi Therapeutics
Via Business Wire
News headline image
Glucotrack, Inc. Announces Reverse Stock Split
August 27, 2026
From Glucotrack, Inc.
Via Business Wire
News headline image
Lōkahi Therapeutics™ Initiates Clinical Trial Manufacturing for LT-100
August 25, 2026
From Lōkahi Therapeutics Inc.
Via Business Wire
News headline image
Lōkahi Therapeutics™ Expands ai² Futures Lab™ Asset Origination Network Through Continued Collaboration with the University of Georgia
August 21, 2026
From Lōkahi Therapeutics
Via Business Wire

Frequently Asked Questions

Is GlucoTrack, Inc. - Common Stock publicly traded?
Yes, GlucoTrack, Inc. - Common Stock is publicly traded.
What exchange does GlucoTrack, Inc. - Common Stock trade on?
GlucoTrack, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for GlucoTrack, Inc. - Common Stock?
The ticker symbol for GlucoTrack, Inc. - Common Stock is GCTK on the Nasdaq Stock Market
What is the current price of GlucoTrack, Inc. - Common Stock?
The current price of GlucoTrack, Inc. - Common Stock is 1.210
When was GlucoTrack, Inc. - Common Stock last traded?
The last trade of GlucoTrack, Inc. - Common Stock was at 10/02/26 04:00 PM ET
What is the market capitalization of GlucoTrack, Inc. - Common Stock?
The market capitalization of GlucoTrack, Inc. - Common Stock is 1.10M
How many shares of GlucoTrack, Inc. - Common Stock are outstanding?
GlucoTrack, Inc. - Common Stock has 1M shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap